PHYSIOLOGICAL EFFECT OF A PROBIOTIC ON SKIN 395 (21) G. Grove, “Age Related Differences in Healing of Superfi cial Skin Wounds in Humans,” in The Effects of Aging in Oral Mucosa and skin, C. A. Squier and M. W. Hill. Eds. (CRC Press, Boca Raton, FL, 1994), pp. 124–125. (22) N. Muizzuddin, D. H. Maes, and T. Mammone, A rapid method to clinically assess the effect of an anti- acne formulation, J. Cosmet. Sci., 60, 25–29 (2009). (23) E. Begon, O. Chosidow, and P. Wolkenstein, Disulone, Ann Dermatol Venereol., 131(12), 1062–1073 (2004). (24) L. H. Kircik, Harnessing the anti-infl ammatory effects of topical dapsone for management of acne, J Drugs Dermatol., 9(6), 667–671 (2010). (25) M. Viljanen, E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure, and M. Kuitunen, Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double- blind placebo-controlled trial, Allergy, 60(4), 494–500 (2005). (26) T. Ogawa, S. Hashikawa, Y. Asai, H. Sakamoto, K. Yasuda, and Y. Makimura, A new synbiotic, Lacto- bacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction, FEMS Immunol Med Microbiol., 46(3), 400–409 (2006). (27) W. P. Bowe and A. C. Logan, Acne vulgaris, probiotics and the gut-brain-skin axis—back to the future, Gut Pathog., 3(1), 1–4 (2011). (28) S. P. Yazdankhah, A. A. Scheie, E. A. Høiby, B. T. Lunestad, E. Heir, T. Ø. Fotland, K. Naterstad, and H. Kruse, Triclosan and antimicrobial resistance in bacteria: an overview, Microb Drug Resist., 12(2), 83–90 (2006).
Purchased for the exclusive use of nofirst nolast (unknown) From: SCC Media Library & Resource Center (library.scconline.org)











































































